Authorized purpose: SIGNA Artist is a 1.5T whole-body MRI system; K202238 adds AIR Recon DL reconstruction to reduce noise and ringing and support improved image quality or shorter acquisitions.
Clinical role
Whole-body MR acquisition and reconstruction with optional AIR Recon DL image reconstruction.
Images and patients
MRI · Multi-region
Key limitation
Keep in mind: Depending on the region of interest being imaged, contrast agents may be used. The addition of the AIR Recon DL feature does not impact the intended use of the SIGNA Artist system.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: SIGNA Artist is a 1.5T whole-body MRI system; K202238 adds AIR Recon DL reconstruction to reduce noise and ringing and support improved image quality or shorter acquisitions.
Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Multi-region Input: The system uses a combination of time varying magnetic fields (gradients) and RF transmissions to obtain information regarding the density and position of elements exhibiting magnetic resonance.
Who uses it?Intended users: Operators of the system and trained physicians interpreting the images and/or spectra.
What does the software produce?Output: Diagnostic MR images, spectra, and derived parameters, including AIR Recon DL reconstructions where enabled.
What is its most important limitation?Key limitation: Depending on the region of interest being imaged, contrast agents may be used. The addition of the AIR Recon DL feature does not impact the intended use of the SIGNA Artist system.
Clinical takeaway. Clinical role: SIGNA Artist is a 1.5T whole-body MRI system; K202238 adds AIR Recon DL reconstruction to reduce noise and ringing and support improved image quality or shorter acquisitions.
Evidence takeaway. Evidence from the reviewed source record: K202238 describes manufacturer AIR Recon DL reconstruction and system testing. Public family materials support current implementation context; reviewed recalls cover missing slices, cryogen venting, orientation, table caster locks, and Low-SAR B1+RMS behavior rather than a single common AI failure mode.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
SIGNA Artist is a 1.5T whole-body MRI system; K202238 adds AIR Recon DL reconstruction to reduce noise and ringing and support improved image quality or shorter acquisitions.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
The system uses a combination of time varying magnetic fields (gradients) and RF transmissions to obtain information regarding the density and position of elements exhibiting magnetic resonance.
Exact FDA submission
Checked 2026-09-19
This is the exact acquisition description; the dossier's supported-coil, sequence, and protocol inventory is not stated in this packet as an input requirement.
Depending on the region of interest being imaged, contrast agents may be used. The addition of the AIR Recon DL feature does not impact the intended use of the SIGNA Artist system.
Exact FDA submission
Checked 2026-09-19
These are the packet's direct labeled-use boundaries; the recalled-device and generalized performance language is not retained.
K202238 describes manufacturer AIR Recon DL reconstruction and system testing. Public family materials support current implementation context; reviewed recalls cover missing slices, cryogen venting, orientation, table caster locks, and Low-SAR B1+RMS behavior rather than a single common AI failure mode.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K202238 describes manufacturer AIR Recon DL reconstruction and system testing. Public family materials support current implementation context; reviewed recalls cover missing slices, cryogen venting, orientation, table caster locks, and Low-SAR B1+RMS behavior rather than a single common AI failure mode.
Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-03
Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K202238 FDA performance package for SIGNA Artist
DesignManufacturer MR system, image-quality, reconstruction, software, safety, and AIR Recon DL verification
PopulationRepresentative whole-body MRI acquisitions and AIR Recon DL reconstruction workflows
Scopeexact submission
Tested versionSIGNA Artist release cleared in K202238
IndependenceSponsor or vendor study
K202238
Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
5 reviewed FDA recall records in the 2026-09-02 openFDA snapshot natively identify K202238. Read the model- and version-scoped events and confirm affected-unit and correction status with the manufacturer. FDA recall Z-0139-2022 affected SIGNA Artist because some slices could be missing and leave a gap of anatomy in three-dimensional volume images. FDA lists the recall as terminated. FDA recall Z-0600-2022 includes superconducting magnets used in SIGNA Artist systems whose cryogen ventilation might not meet venting requirements. FDA lists the recall as open and classified. FDA recall Z-2061-2021 affected SIGNA Artist because an unintended patient-orientation change before the initial localizer could produce incorrectly annotated or flipped images. FDA lists the recall as open and classified. FDA recall Z-2299-2025 includes SIGNA Artist patient tables because planned maintenance might omit checks of caster-lock function, allowing movement during patient transfer. FDA lists the recall as open and classified. FDA recall Z-2469-2024 includes SIGNA Artist software DV26.0 through MR30.1 because predicted B1+RMS could exceed the prescribed Low SAR limit for specified FLAIR configurations and overheat an MR-conditional implant. FDA lists the recall as open and classified.
FDA source
Exact FDA submission
Checked 2026-09-04
Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.
Exact system-family match. This is a magnet-room and cryogen-venting issue, not an AIR Recon DL algorithm defect; confirm affected magnet and ventilation inspection status.
Exact SIGNA Artist model match. Verify the correction and ensure the prescribed orientation is checked against actual patient position before scanning.
Exact system-model match. This is a patient-table maintenance issue, not an AIR Recon DL algorithm defect; confirm inspection and corrective-action status.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: The system uses a combination of time varying magnetic fields (gradients) and RF transmissions to obtain information regarding the density and position of elements exhibiting magnetic resonance.
Scope: Exact FDA submission. This is the exact acquisition description; the dossier's supported-coil, sequence, and protocol inventory is not stated in this packet as an input requirement.
Confirm scanner/model, protocol, series completeness and both software builds.
Unresolved route: Diagnostic MR images, spectra, and derived parameters, including AIR Recon DL reconstructions where enabled.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Only mr technologists and trained operators, with images and spectra interpreted by trained physicians. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: AIR Recon DL performance depends on sequence, anatomy, protocol, and installed software. Exact affected units and correction status must be checked for the five reviewed SIGNA Artist recalls.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. AIR Recon DL performance depends on sequence, anatomy, protocol, and installed software. Exact affected units and correction status must be checked for the five reviewed SIGNA Artist recalls.
exact submission · checked 2026-09-03
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03
Vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: AIR Recon DL performance depends on sequence, anatomy, protocol, and installed software. Exact affected units and correction status must be checked for the five reviewed SIGNA Artist recalls.
exact submission · checked 2026-09-03
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
27Fields reviewed
11Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate record. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 5 FDA recall candidates were manually reviewed: 5 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 5 postmarket candidate records; 5 have been reviewed (5 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-03 - Exact FDA submission
Public materials reviewed for this batch do not establish the complete security posture for the exact release. Request data-flow, identity, audit, encryption, retention, support-access, vulnerability-management, backup, and incident-response evidence.
Authorized purpose: Vantage Fortian and Orian 1.5T produce diagnostic MR images of the head and body, including labeled noncontrast angiography, for trained technologists and physician interpretation.
Authorized purpose: S-scan Open is an Esaote MR system for diagnostic image acquisition, reconstruction, display, and professional interpretation within the labeled scanner, coil, sequence, and anatomy scope.
Authorized purpose: AIR Recon DL adds a deep-learning phase-correction and reconstruction option to supported GE 1.5T, 3T, and 7T MR workflows for all labeled anatomies and ages to reduce noise or ringing and support image quality or scan-time choices.
Authorized purpose: The listed MAGNETOM 1.5T and 3T MRI systems produce cross-sectional images, spectroscopic images or spectra, and derived physical parameters of the head, body, and extremities for trained-physician interpretation and can support imaging during MR-compatible interventions.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.